United States Veterinary Glucose Monitoring Devices Market Size, Share, and COVID-19 Impact Analysis, By Animal Type (Dogs, Cats, Horses, and Others) By End-use (Veterinary Hospitals & Clinics, Home Care Settings, Veterinary Diagnostic Centers, and Others), and United States Veterinary Glucose Monitoring Devices Market Insights, Industry Trend, Forecasts to 2035

United States Veterinary Glucose Monitoring Devices Market Insights Forecasts to 2035

• The United States Veterinary Glucose Monitoring Devices Market Size Was Estimated at USD 262.20 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 6.16% from 2025 to 2035
• The United States Veterinary Glucose Monitoring Devices Market Size is Expected to Reach USD 505.80 Million by 2035

According to a research report published by Spherical Insights & Consulting, the United States veterinary glucose monitoring devices market Size is anticipated to reach USD 505.80 Million by 2035, growing at a CAGR of 6.16% from 2025 to 2035.  The U.S. veterinary glucose monitoring devices market is growing due to rising pet diabetes cases, increasing pet health awareness, and the trend of pet humanization. Technological advancements have made monitoring devices more accurate and user-friendly.

Market Overview

The United States veterinary glucose monitoring devices market defines the segment of veterinary healthcare focused on devices that measure blood glucose levels in animals, particularly for managing diabetes in companion pets like dogs and cats. This market is growing steadily, driven by the increasing prevalence of diabetes among pets, attributed to rising obesity rates, sedentary lifestyles, and aging animal populations. Key drivers include technological advancements in monitoring systems, such as Bluetooth-enabled and smartphone-integrated devices, which improve usability and accuracy for both veterinarians and pet owners. A major strength of the market lies in the growing trend of pet humanization, leading to higher spending on pet health and wellness. Additionally, increasing awareness about chronic pet diseases and better diagnostic capabilities present significant growth opportunities. The expanding reach of pet insurance, which now often covers chronic conditions like diabetes, further supports device adoption. Although government initiatives in this specific segment are limited, broader support for animal health and innovation in medical devices indirectly benefits the market.

Report Coverage

This research report categorizes the market for the United States veterinary glucose monitoring devices market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United States veterinary glucose monitoring devices market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United States veterinary glucose monitoring devices market.

Driving Factors

The rising prevalence of diabetes in pets, especially dogs and cats, is often linked to obesity, aging, and sedentary lifestyles. As more pets are diagnosed with diabetes, the demand for accurate, easy-to-use glucose monitoring tools increases. Technological advancements, such as Bluetooth-enabled meters, smartphone integration, and cloud-based data tracking, are making glucose monitoring more convenient for both veterinarians and pet owners. The growing trend of pet humanization has also led to greater spending on advanced pet healthcare. Furthermore, increased awareness of chronic conditions in animals, along with the expansion of pet insurance coverage, has made these monitoring devices more accessible. Together, these factors are fueling strong growth across the U.S. veterinary glucose monitoring market.

Restraining Factors

The expensive devices, lack of awareness among pet owners about pet diabetes, and difficulties in precise glucose monitoring in animals caused by physiological variations. Additionally, limited reimbursement policies and a shortage of specialized veterinary professionals can hinder wider adoption and accessibility of these devices.

Market Segmentation

The United States veterinary glucose monitoring devices market share is classified into animal type and end-use.

• The dogs segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United States veterinary glucose monitoring devices market is segmented by animal type into dogs, cats, horses, and others. Among these, the dogs segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to the higher incidence of diabetes in dogs, their larger pet population, and increased owner awareness. Frequent veterinary visits and better compliance with treatment also drive demand for glucose monitoring devices in dogs.

• The veterinary hospitals & clinics segment held a substantial share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United States veterinary glucose monitoring devices market is segmented by end-use into veterinary hospitals & clinics, home care settings, veterinary diagnostic centers, and others. Among these, the veterinary hospitals & clinics segment held a substantial share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is because they are the primary centers for the diagnosis and treatment of pet diabetes. These facilities have access to advanced monitoring devices, trained professionals, and offer consistent care, making them the preferred choice for managing diabetic pets effectively.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United States veterinary glucose monitoring devices market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Taidoc Technology Corporation
• IDEXX Laboratories, Inc.
• ACON Laboratories, Inc.
• Elanco Animal Health
• AccuBioTech Co., Ltd.
• Abbott Laboratories
• Allison Medical, Inc.
• Trividia Health, Inc.
• Teco Diagnostics
• Medtronic plc
• Dexcom, Inc.
• UltiMed, Inc.
• i-SENS, Inc.
• Zoetis Inc.
• Bayer AG
• Others

Recent Developments:

• In February 2023, Zoetis announced the U.S. launch of the AlphaTrak 3 glucose monitoring system for cats, dogs. This device offers results in as little as 5 seconds, requires a small sample volume of 0.3 microliters, and features a mobile app for data sharing between pet owners and veterinary teams.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the USA, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the U.S. veterinary glucose monitoring devices market based on the below-mentioned segments:

United States Veterinary Glucose Monitoring Devices Market, By Animal Type

• Dogs
• Cats
• Horses
• Others

United States Veterinary Glucose Monitoring Devices Market, By End-use  

• Veterinary Hospitals & Clinics
• Home Care Settings
• Veterinary Diagnostic Centers
• Others